LRRC32 and cancer: Glycoprotein-A repetitions predominant (GARP) is a cell surface docking receptor for activating latent TGFβ1, TGFβ2, and TGFβ3, with its expression restricted predominantly to effector Treg and cancer cells [2, 40].